Organization and research areas

The Josep Carreras Leukaemia Research Institute is spread across two campuses which share a coordinated task: Campus Clínic, located in the buildings of the Hospital Clínic in Barcelona; the Faculty of Medicine of the UB, the August Pi i Suner Institute of Biomedical Research (IDIBAPS); and the Campus ICO/Germans Trias i Pujol, located in the area surrounding the Hospital Universitario Germans Trias i Pujol in Badalona, the Faculty of Medicine at the Autonomous University of Barcelona, the Germans Trias i Pujol Institute for Research into Health Sciences (FIICSGTIP) and the IMPPC.

Scientific Research

The Clínic Campus has the Haematology Services research laboratories of the Haemopathology Unit and the Faculty of Medicine. In order to create the Germans Trias i Pujol Campus, the City Council of Badalona has provided land adjacent to the Hospital, upon which the José Carreras Foundation will construct a new building and will provide equipment required by both research campuses. This support has been valued at €14,000,000. The initial support for the project on behalf of the Civil Society of Badalona has come from the Badalona Rotary Club and the Badalona Foundation against Cancer.

For its part, the Generalitat de Catalunya is committed to annual funding sufficient to guarantee the running of the Josep Carreras Leukaemia Research Institute.

Scientific Research

Upon achieving the complete deployment of the 8 to 10 envisaged research teams, the Institute will have 100 staff, including researchers and auxiliaries. In addition to its own Campuses, the Institute will establish partnership agreements with other research centres, both national and international. The scientific leadership of the José Carreras International Institute for Leukaemia Research will be of global significance and will aim to attract the most distinguished researchers in the field of haematology.

 

Instituto de investigación render laboratorio tipo

The opportunities represented by research into leukaemia and other malignant blood diseases are clear. Strategies to respond to these opportunities must make use of methodologies and technologies that fit with the challenges presented by the fight in order to be able to cure these illnesses. To this end, the research areas to be established in the Josep Carreras Leukaemia Research Institute research will be:

GENERAL RESEARCH LINES

  1. Acute Leukaemia
  2. Chronic Lymphoproliferative Syndromes
  3. Chronic Myeloproliferative Neoplasms
  4. Monoclonal Gammopathies
  5. Myelodysplastic Syndromes
  6. Malignant hemopathies and coagulation
  7. Complications due to therapeutic procedures
  8. Transplants of hematopoietic progenitors and Cellular therapy
  9. Epidemiologic research
  10. Clinical research
Webpage updated 04/16/2014 18:03:35